Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Antithrombotic Therapy After Transcatheter Aortic Valve Implantation
Author(s): Leslie Marisol Lugo , Rafael Romaguera , Joan Antoni Gómez-Hospital , et al Added: 3 years ago
Transcatheter aortic valve implantation (TAVI) is the therapy of choice for patients with symptomatic severe aortic stenosis who are unsuitable for surgical aortic valve replacement and for elderly patients with high operative risk.1,2 It is also considered to be a more than valid and reasonable alternative to surgical aortic valve replacement for patients with moderate to high surgical risk.3,4… View more

Anticoagulation
Dual Antithrombotic Therapy With Dabigatran
Author(s): Christopher P Cannon Added: 6 years ago
This interview with Christopher P. Cannon from Brigham and Women's Hospital, Boston, US discusses Dual Antithrombotic Therapy with Dabigatran After Percutaneous Coronary Intervention in Patients with Atrial Fibrillation (REDUAL-PCI). Filmed by Radcliffe Cardiology on-site at ESC 2017. View more

Anticoagulation
ESC 22: COVID-PACT: Antithrombotic Therapy in Critically Ill COVID-19 Pts
Author(s): David Berg Added: 1 year ago
ESC Congress 22 — Dr David Berg (Brigham and Women's Hospital, US) shares key results from the TIMI Study Group's COVID-PACT trial (NCT04409834). This multicenter, randomized-controlled trial assessed efficacy and safety of full-dose vs. standard prophylactic dose anticoagulation and of antiplatelet vs. no antiplatelet therapy for prevention of venous and arterial thrombotic events. The study… View more

Anticoagulation

Vascular Disease and Surgery
Difficulties in Monitoring Antithrombotic Therapy in Patients with Atrial Fibrillation and Post-traumatic Hepatic and Splenic Visceral Haematomas
Author(s): Maria Cristina Beznă , Suzana Dănoiu , Marinela Beznă , et al Added: 12 months ago

Anticoagulation

Electrophysiology & Arrhythmia
ENVISAGE-TAVI AF: Edoxaban noninferior to warfarin for adverse events after TAVI
Author(s): George D Dangas Added: 2 years ago
In this short video, Dr George Dangas (Mount Sinai Hospital, New York, NY, US) shares the findings from the ENVISAGE-TAVI AF hot line trial presented at ESC Congress 2021. ENVISAGE-TAVI AF (Daiichi-Sankyo) compared the safety and efficacy of the DOAC edoxaban with VKAs (warfarin and its analogues) in atrial fibrillation patients with an indication for oral anticoagulation after successful TAVI. … View more

Anticoagulation

Electrophysiology & Arrhythmia
Direct-acting Anticoagulants in Chronic Coronary Syndromes
Author(s): Emmanuel Sorbets , Philippe Gabriel Steg Added: 3 years ago
Despite improvements in the management of coronary artery disease over the last decades, ischaemic heart disease remains the leading cause of mortality worldwide and the leading cause of premature death.1,2 Patients with chronic coronary syndromes (CCS) encompass a heterogeneous population, including those with demonstrable coronary artery disease by anatomical testing or evidence of ischaemia,… View more

Anticoagulation

Electrophysiology & Arrhythmia
Boyoung Joung
Research Area(s) / Expertise:

Atrial Arrhythmias

Atrial Fibrillation

Catheter Ablation of Cardiac Arrhythmias

Stroke
Prof Boyoung Joung is the Professor of Internal Medicine at theYonsei University in Seoul, South Korea. His research interests include atrial fibrillation, stroke, hypertension, and antithrombotic therapy. Prof Joung is a member of theArrhythmia & Electrophysiology Revieweditorial board. View more
Author(s): Nadzeya Kuzniatsova , Gregory YH Lip Added: 3 years ago
Atrial fibrillation (AF) is the most common cardiac rhythm disorder in everyday clinical practice, affecting 1–2% of the general population. The prevalence of AF is strongly age-dependent, increasing from <1% in patients under 60 years of age to almost 10% in patients 80 years of age or older1 and 17.8% in those 85 years of age and above.2 Population-based studies have shown lifetime risks for… View more

Electrophysiology & Arrhythmia

Prevention & Chronic Conditions
John Eikelboom
Research Area(s) / Expertise: Job title: Associate Professor
Dr John Eikelboom is an Associate Professor in the Department of Medicine at McMaster University in Hamilton , Ontario . Dr Eikelboom earned his MBBS degree at the University of Western Australia Medical School, Australia and he completed training in Internal Medicine and Haematology at Royal Perth Hospital , Australia and trained in Epidemiology and Thrombosis Medicine at McMaster University … View more
Kurt Huber
Job title: Head of the 3rd Med. Dept. of Cardiology and Internal Intensive Care Medicine
Prof Kurt Huber is Head of the 3rd Med. Dept. with Cardiology and Internal Intensive Care Medicine at the Clinic Ottakring, Vienna. Prof Huber is an interventional cardiologist with over 35 years of experience. His main research interest covers basic research (mechanisms of thrombus formation and dissolution) as well as clinical research (acute coronary syndromes, organization of STEMI… View more